ReShape Lifesciences Inc. (NASDAQ:RSLS) Short Interest Up 40.4% in January

ReShape Lifesciences Inc. (NASDAQ:RSLS) was the target of a large growth in short interest during the month of January. As of January 31st, there was short interest totalling 22,600 shares, a growth of 40.4% from the January 15th total of 16,100 shares. Based on an average daily volume of 59,800 shares, the short-interest ratio is presently 0.4 days. Approximately 3.3% of the shares of the company are short sold.

ReShape Lifesciences Trading Down 8.3 %

ReShape Lifesciences stock traded down $0.21 during trading hours on Friday, hitting $2.33. The stock had a trading volume of 123,469 shares, compared to its average volume of 47,470. The company has a 50-day moving average of $4.21 and a two-hundred day moving average of $6.17. ReShape Lifesciences has a fifty-two week low of $2.32 and a fifty-two week high of $29.00.

About ReShape Lifesciences

ReShape Lifesciences Inc provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; Lap-Band 2.0 System, an adjustable postoperatively to increase or decrease the pressure to the band in order to optimize an individual's comfort and therapy effectiveness; and ReShape Calibration Tubes, that fits the lesser curvature of the stomach to reach the pylorus.